Position
Chief Medical Officer
Company
Celea Therapeutics
BostonBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Celea Therapeutics has announced the appointment of Paul Audhya, MD, MBA, as their new Chief Medical Officer. This decision reflects the company's commitment to strengthening its leadership in the biopharmaceutical sector.
Quick answer
Celea Therapeutics Appoints Paul Audhya as Chief Medical Officer (October 29, 2026). Celea Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Medical Officer at Celea Therapeutics?
- Celea Therapeutics named Paul Audhya Chief Medical Officer, announced October 29, 2026.
- What did Celea Therapeutics announce on October 29, 2026?
- Celea Therapeutics has announced the appointment of Paul Audhya, MD, MBA, as their new Chief Medical Officer. This decision reflects the company's commitment to strengthening its leadership in the biopharmaceutical sector.
- What does Celea Therapeutics do?
- Celea Therapeutics is a clinical-stage biopharmaceutical company dedicated to advancing transformative treatments for people with serious respiratory diseases.
- Where is Celea Therapeutics based?
- Celea Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Harmony Biosciences (October 30, 2026), Estrella Immunopharma (October 26, 2026), Cantargia AB (October 26, 2026) and AlzeCure Pharma (November 1, 2026) also announced leadership changes within 45 days of Celea Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Peter Anastasiou Appointed as President and CEO of Harmony Biosciences (October 30, 2026)
- Estrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer (October 26, 2026)
- Cantargia AB Appoints Monic Stuart as Chief Medical Officer (October 26, 2026)
- AlzeCure Pharma Appoints Johan Sandin as Acting CEO and Pontus Forsell as Deputy CEO (November 1, 2026)
- Oculis Appoints Björn Tackenberg as Chief Scientific Officer (November 2, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
Who to call at Celea Therapeutics, and when
A new leader at Celea Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Celea Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Celea Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Celea Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Celea Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Celea Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.